.INVESTIGATION HIGHLIGHT.06 August 2024.
A big randomized regulated test with cisgender girls highlights the difficulties of adherence to a regular oral preexposure prevention program and shows that twice-yearly injection of lenacapavir may maintain helpful HIV protection levels over 6 months.